Neue Formeln zur Schätzung der Nierenfunktion–Bedeutung für die Dosierung nierengängiger Arzneimittel

N Ebert - Die Innere Medizin, 2024 - Springer
Hintergrund Generell gilt, dass von der Nierenfunktion wichtige Therapieentscheidungen
abhängen, weshalb ihrer korrekten Bestimmung große Bedeutung zukommt. Dies spielt …

Application of Physiologically Based Pharmacokinetic and Pharmacodynamic (PBPK/PD) Modeling Comprising Transporters: Delineating the Role of Various Factors …

MD Harwood, A Rostami‐Hodjegan… - … and Role in Drug …, 2022 - Wiley Online Library
Physiologically based pharmacokinetic models (PBPK) provide an in silico framework that
integrates biological, drug, and trial design information to predict drug fate. Information on …

[PDF][PDF] Comment on: the pharmacokinetics of metformin in patients receiving intermittent haemodialysis by Sinnappah, et al

GT Tucker, CA Wesolowski - Br J Clin Pharmacol, 2021 - researchgate.net
Based on a population pharmacokinetic model, Sinnappah et al. 1 have recently suggested
that oral metformin HCl doses of 250–500 mg post-dialysis or 250 mg daily should be safe to …

Impact of drug-gene-disease interactions and diurnal variation on exogenous and endogenous renal transporter substrates: a physiologically based pharmacokinetic …

D Feick - 2022 - publikationen.sulb.uni-saarland.de
Adverse drug reactions depict one of the leading causes of death in developed countries
and can often be attributed to drug-drug, drug-gene and drug-disease interactions …

[PDF][PDF] Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure

W Xie, J Li, C Kong, W Luo, J Zheng, Y Zhou - scholar.archive.org
Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure: A
Pharmacovigilance-Pharmacokinetic Appraisa Page 1 Metformin-Cimetidine Drug Interaction …

IMPACT OF 420DEL (RS72552763) ORGANIC CATION TRANSPORTER 1 POLYMORPHISM ON THERAPEUTIC RESPONSE TO METFORMIN IN TYPE2 DIABETIC …

HK Jabaar, BH Khalaf… - … & Cellular Archives, 2022 - search.ebscohost.com
Metformin is one of the most widely prescribed medications for the treatment of type 2
diabetes (T2DM) but metformin response varies greatly between individuals, polymorphisms …

[PDF][PDF] IMPACT OF DRUG-GENE-DISEASE INTERACTIONS AND DIURNAL VARIATION ON EXOGENOUS AND ENDOGENOUS RENAL TRANSPORTER …

APB PHARMACOKINETIC - scholar.archive.org
Adverse drug reactions depict one of the leading causes of death in developed countries
and can often be attributed to drug-drug, druggene and drug-disease interactions. However …

[PDF][PDF] 薬物トランスポーター内因性バイオマーカーを用いて慢性腎障害患者での薬物間相互作用を定量的に解析する手法の開発

滝田浩之, タキタヒロユキ - kitasato.repo.nii.ac.jp
博士論文 Quantitative analysis of drug-drug interaction in chronic kidney disease patients
using endogenous transporter biom Page 1 1 博士論文 Quantitative analysis of drug-drug …